翰宇药业：11月17日召开董事会会议

Group 1 - The core point of the article is that Hanyu Pharmaceutical (SZ 300199) held its 10th meeting of the 6th Board of Directors on November 17, 2025, to review various documents, including a proposal to amend the "Annual Work System of the Board Audit Committee" [1] - For the first half of 2025, Hanyu Pharmaceutical's revenue composition is entirely from the pharmaceutical manufacturing industry, accounting for 100.0% [1] - As of the time of reporting, Hanyu Pharmaceutical has a market capitalization of 17.1 billion yuan [2]